TIGIT 抗体
Our Local Distributor
北京 101111
Quick Overview for TIGIT 抗体 (ABIN7862150)
抗原
See all TIGIT 抗体适用
宿主
克隆类型
标记
应用范围
克隆位点
-
-
原理
- TIGIT / VSTM3 / VSIG9 (Immune Checkpoint for Cancer) Antibody
-
特异性
- TIGIT is a checkpoint inhibitor which binds with high affinity to the poliovirus receptor (PVR), causing increased IL10 secretion, decreased IL12B secretion. TIGIT binding to PVR also causes the suppression of T cell activation by promoting the generation of mature immuno-regulatory dendritic cells. It is expressed at low levels on natural killer (NK) cells, as well as peripheral memory and regulatory CD4+ T cells. At the protein level, it is upregulated following the activation of these cells. Functionally, TIGIT is similar to CTLA4. The ligands for TIGIT include CD155 (signal abrogation) and CD226 (signal stimulation). It has been demonstrated to be upregulated on T cells in many cancers and is an immuno-oncology target for therapy.
-
纯化方法
- 200ug/ml of Ab Purified from Bioreactor Concentrate by Protein A/G.
-
免疫原
- Recombinant full-length human TIGIT protein
-
亚型
- IgG1, kappa
-
-
-
-
应用备注
- Optimal working dilution should be determined by the investigator.
-
限制
- 仅限研究用
-
-
-
浓度
- 1.0 mg/mL
-
缓冲液
- Prepared in 10 mM PBS
-
储存液
- Azide free
-
储存条件
- -20 °C,-80 °C
-
储存方法
- Antibody with azide - store at 2 to 8°C. Antibody without azide - store at -20 to -80°C. Antibody is stable for 24 months. Non-hazardous. No MSDS required.
-
有效期
- 24 months
-
-
- TIGIT (T Cell Immunoreceptor with Ig and ITIM Domains (TIGIT))
-
别名
- TIGIT
-
背景
-
T-cell immunoreceptor with Ig and ITIM domains, V-set and immunoglobulin domain containing 9 (VSIG9), V-set and transmembrane domain containing 3 (VSTM3), Washington University cell adhesion molecule (WUCAM)
Molt-4 cells. Human prostate or colon carcinoma.
-
分子量
- 26kDa
-
基因ID
- 201633, 421750
-
UniProt
- Q495A1
-
途径
- Cancer Immune Checkpoints
抗原
-